<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref26">
 <mixed-citation publication-type="journal" id="cit26">
  <name>
   <surname>Nico</surname>
   <given-names>D.</given-names>
  </name>; 
  <name>
   <surname>Gomes</surname>
   <given-names>D. C.</given-names>
  </name>; 
  <name>
   <surname>Palatnik-de-Sousa</surname>
   <given-names>I.</given-names>
  </name>; 
  <name>
   <surname>Morrot</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Palatnik</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Palatnik-de-Sousa</surname>
   <given-names>C. B.</given-names>
  </name>
  <article-title>
   <italic>Leishmania donovani</italic> Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection
  </article-title>. 
  <source>Front. Immunol.</source>
  <year>2014</year>, 
  <volume>5</volume>, 
  <fpage>273</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2014.00273</pub-id>.
  <pub-id pub-id-type="pmid">24966857</pub-id>
 </mixed-citation>
</ref>
